Literature DB >> 11568049

Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation.

S Tabbutt1, C Ramamoorthy, L M Montenegro, S M Durning, C D Kurth, J M Steven, R I Godinez, T L Spray, G Wernovsky, S C Nicolson.   

Abstract

BACKGROUND: Management strategies for preoperative infants with hypoplastic left heart syndrome (HLHS) include increased inspired nitrogen (hypoxia) and increased inspired carbon dioxide (hypercarbia). There are no studies directly comparing these 2 therapies in humans. This study compares the impact of hypoxia versus hypercarbia on oxygen delivery, under conditions of fixed minute ventilation. METHODS AND
RESULTS: Ten anesthetized and paralyzed preoperative infants with HLHS were evaluated in a prospective, randomized, crossover trial comparing hypoxia (17% FIO(2)) with hypercarbia (2.7% FICO(2)). Each patient was treated in a random order (10 minutes per condition) with a recovery period (15 to 20 minutes) in room air. Arterial (SaO(2)) and superior vena caval (SvO(2)) co-oximetry and cerebral oxygen saturation (ScO(2)) measurements were made at the end of each condition and recovery period. ScO(2) was measured by near infrared spectroscopy. Hypoxia significantly decreased both SaO(2) (-5.2+/-1.1%, P=0.0014) and SvO(2) (-5.6+/-1.7%, P=0.009) compared with baseline, but arteriovenous oxygen saturation (AVO(2)) difference (SaO(2)-SvO(2)) and ScO(2) remained unchanged. Hypercarbia decreased SaO(2) (-2.6+/-0.6%, P=0.002) compared with baseline but increased both ScO(2) (9.6+/-1.8%, P=0.0001) and SvO(2) (6+/-2.2%, P=0.022) and narrowed the AVO(2) difference (-8.5+/-2.3%, P=0.005). Both hypoxia and hypercarbia decreased the balance between pulmonary and systemic blood flow (Qp:Qs) compared with baseline.
CONCLUSIONS: In preoperative infants with HLHS, under conditions of anesthesia and paralysis, although Qp:Qs falls in both conditions, oxygen delivery is unchanged during hypoxia and increased during hypercarbia. These data cannot differentiate cerebral from systemic oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568049     DOI: 10.1161/hc37t1.094818

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Validation of diffuse correlation spectroscopic measurement of cerebral blood flow using phase-encoded velocity mapping magnetic resonance imaging.

Authors:  Erin M Buckley; Dalton Hance; Thomas Pawlowski; Jennifer Lynch; Felice B Wilson; Rickson C Mesquita; Turgut Durduran; Laura K Diaz; Mary E Putt; Daniel J Licht; Mark A Fogel; Arjun G Yodh
Journal:  J Biomed Opt       Date:  2012-03       Impact factor: 3.170

2.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

3.  Optical measurement of cerebral hemodynamics and oxygen metabolism in neonates with congenital heart defects.

Authors:  Turgut Durduran; Chao Zhou; Erin M Buckley; Meeri N Kim; Guoqiang Yu; Regine Choe; J William Gaynor; Thomas L Spray; Suzanne M Durning; Stefanie E Mason; Lisa M Montenegro; Susan C Nicolson; Robert A Zimmerman; Mary E Putt; Jiongjiong Wang; Joel H Greenberg; John A Detre; Arjun G Yodh; Daniel J Licht
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

4.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

5.  Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome.

Authors:  Luca Di Chiara; Zaccaria Ricci; Cristiana Garisto; Stefano Morelli; Chiara Giorni; Vincenzo Vitale; Roberto M Di Donato; Sergio Picardo
Journal:  Pediatr Cardiol       Date:  2010-01       Impact factor: 1.655

Review 6.  The intensive care of infants with hypoplastic left heart syndrome.

Authors:  U Theilen; L Shekerdemian
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

7.  Diagnosis influences response of cerebral near infrared spectroscopy to intracranial hypertension in children.

Authors:  Maria T Zuluaga; Megan E Esch; Natalie Z Cvijanovich; Nalin Gupta; Patrick S McQuillen
Journal:  Pediatr Crit Care Med       Date:  2010-07       Impact factor: 3.624

8.  Cardio-renal recovery of hypoxic newborn pigs after 18%, 21% and 100% reoxygenation.

Authors:  Po-Yin Cheung; Laila Obaid; Marwan Emara; Yann Brierley; Scott T Johnson; Grace S Chan; Laurence Jewell; Gregory Korbutt; David L Bigam
Journal:  Intensive Care Med       Date:  2008-01-31       Impact factor: 17.440

9.  Variability in the preoperative management of infants with hypoplastic left heart syndrome.

Authors:  B A Johnson; K Mussatto; M R Uhing; H Zimmerman; J Tweddell; N Ghanayem
Journal:  Pediatr Cardiol       Date:  2007-11-22       Impact factor: 1.655

10.  Improved pretransplant management of infants with hypoplastic left heart syndrome enables discharge to home while waiting for transplantation.

Authors:  K D Bourke; H M Sondheimer; D D Ivy; B Pietra; B K Gleason; C Mashburn; M M Boucek
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.